H

HUTCHMED (China) Limited
D

HCM

17.360
USD
-0.33
(-1.87%)
Market Closed
Volume
800
EPS
0
Div Yield
-
P/E
-69
Market Cap
2,967,317,961
News

Title: HUTCHMED (China) Limited

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.